-
JJET’s IPO on STAR Market Accepted, Aims to Raise RMB 2.691 Billion for Medical Device Expansion
•
China-based JJET has received acceptance for its Initial Public Offering (IPO) filing on the Shanghai Stock Exchange’s Sci-Tech Innovation Board (STAR). The offering is anticipated to raise RMB 2.691 billion (USD 375.9 million), with the proceeds earmarked for the construction of the company’s medical device research and development and technology…
-
JJET Raises RMB 700M in Series A+ and B Rounds for Cardiac Electrophysiology Products
•
JJET, a Chengdu-based specialist in cardiac electrophysiology interventional therapy, has completed Series A+ and Series B financing rounds, raising a total of RMB 700 million (USD 102.5 million). Investors include SinoRock, Guanghua Wutong Equity Investment Fund, YuanHengLiZhen, Weigao Holding, and HM Capital. The funding follows a Series A round led…
